I must admit i always had the feeling Robert Hayes jumped on board with Pyc because he liked something he saw when involved with pyc and Janssens deal. At the time i had no idea about most of what we were doing on a technical level, probably still dont, but i wonder if these links are starting to strengthen and might produce that elusive client with a useful payload that they just need to get into cells and escape endosome? Obviously he has stayed around, i was never aware of his link to Centryns and vould only guess it would still be of interest to him.
We could do that for them and now prove it using Cre?? And maybe even with a range of cell specific fpp's if all the stars align.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)